Metropolitan Life Insurance Company (MetLife)’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-21,814
| Closed | -$387K | – | 2609 |
|
|
2018
Q3 | $387K | Hold |
21,814
| – | – | 0.01% | 1548 |
|
|
2018
Q2 | $301K | Buy |
+21,814
| New | +$301K | ﹤0.01% | 1657 |
|
|
2015
Q4 | – | Sell |
-29,340
| Closed | -$134K | – | 2668 |
|
|
2015
Q3 | $134K | Buy |
+29,340
| New | +$134K | ﹤0.01% | 2523 |
|
|
2015
Q2 | – | Sell |
-33,505
| Closed | -$210K | – | 2720 |
|
|
2015
Q1 | $210K | Buy |
33,505
+168
| +0.5% | +$1.05K | ﹤0.01% | 2033 |
|
|
2014
Q4 | $210K | Hold |
33,337
| – | – | ﹤0.01% | 2385 |
|
|
2014
Q3 | $203K | Hold |
33,337
| – | – | ﹤0.01% | 2356 |
|
|
2014
Q2 | $220K | Buy |
33,337
+7,129
| +27% | +$47K | ﹤0.01% | 2453 |
|
|
2014
Q1 | $624K | Hold |
26,208
| – | – | ﹤0.01% | 1653 |
|
|
2013
Q4 | $280K | Hold |
26,208
| – | – | ﹤0.01% | 2230 |
|
|
2013
Q3 | $349K | Hold |
26,208
| – | – | ﹤0.01% | 1996 |
|
|
2013
Q2 | $344K | Buy |
+26,208
| New | +$344K | ﹤0.01% | 1946 |
|